FocusPolicy

Ethics, Error, and Initial Trials of Efficacy

Science Translational Medicine  08 May 2013:
Vol. 5, Issue 184, pp. 184fs16
DOI: 10.1126/scitranslmed.3005684

You are currently viewing the abstract.

View Full Text

Abstract

Clinical trial reforms aimed at boosting phase 2 positive predictivity may involve ethical and social trade-offs.

View Full Text